NICHD Pelvic Floor Disorders Network
17
3
4
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
5.9%
1 terminated/withdrawn out of 17 trials
92.3%
+5.8% vs industry average
35%
6 trials in Phase 3/4
108%
13 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Role: lead
Accelerometer Measured Early Recovery After Prolapse Surgery
Role: lead
Training for Urinary Leakage Improvement After Pregnancy
Role: lead
Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design
Role: lead
Study of Uterine Prolapse Procedures - Randomized Trial
Role: lead
Sling vs Botox for Mixed Incontinence
Role: lead
Neuromodulation for Accidental Bowel Leakage
Role: lead
Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse
Role: lead
Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
Role: lead
The Extended Operations And Pelvic Muscle Training In The Management Of Apical Support Loss Study
Role: lead
Behavioral Therapy Of Obstetric Sphincter Tears
Role: lead
Combined Treatment for Mixed Incontinence
Role: lead
Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)
Role: lead
ATLAS: Ambulatory Treatments for Leakage Associated With Stress
Role: lead
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Role: lead
Anticholinergic vs. Botox Comparison Study
Role: lead
Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
Role: lead
All 17 trials loaded